Experts to consider Pfizer’s India application this week

“The matter has been referred to the Subject Expert Committee (SEC), the panel that advises the Drug Controller General of India on new drugs and vaccine approvals,” a senior government official told ET.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37F1zw9
via IFTTT